In breast cancers CD44+/CD24−/low cells are predominately limited to triple negative breast cancer, a subgroup of basal-like tumors, and the presence of the CD44+/CD24−/low subset is correlated inversely with breast cancer patient survival [4], [5]. This evidence concerns the gene CD44 and triple-negative breast carcinoma.